How to Write a Structured Abstract for a Medical Journal

Many readers, and many databases, see only your abstract. It has to stand on its own and match the full paper exactly.

Guide · 11 min read · Directive Publications Editorial Team

Why the abstract has to stand on its own

The abstract is the part of your paper that travels. The ICMJE Recommendations note that abstracts are the only substantive portion of the article indexed in many electronic databases, and the only portion many readers read. An editor weighing whether to send the paper for review, a clinician scanning search results and a systematic reviewer screening records often see the abstract first, and sometimes see nothing else.

That gives the abstract two jobs.

It must be complete. A reader who sees only the abstract should be able to say what question was asked, in whom, by what design, what was found and how precisely, and what the authors conclude. If any of those is missing, the abstract is not finished.

It must agree with the paper. The ICMJE notes that information in abstracts often differs from that in the text. The CONSORT 2025 guidance adds that the abstract should not include information that does not appear in the body of the paper. Either problem gives an editor or reviewer a reason to doubt the rest of the manuscript.

One thing the abstract is not: a cover letter. The abstract describes the study for any reader; the cover letter argues fit to one editor. Our guide to writing a journal cover letter explains why copying your abstract into the letter wastes it.

The headings and what goes under each

There is no single structured abstract format. The ICMJE requires structured abstracts for original research, systematic reviews and meta-analyses, but notes that the required format differs from journal to journal and that some journals use more than one. Prepare yours in the format your target journal specifies, using its labels exactly.

The labels vary more than the content does. The US National Library of Medicine maps the many headings journals use onto five broad categories for MEDLINE: background, objective, methods, results and conclusions. Whatever your journal calls its boxes, this is the content they need to hold:

If your journal uses an extended format, with separate headings such as design, setting, participants and interventions, the same Methods content is simply split into more boxes. If it merges Background and Objective, keep both elements under one label. Do not add headings the journal does not list, and check the instructions for your article type, since case reports and narrative reviews may use a different structure or none.

Use the abstract checklist for your study design

The major reporting guidelines define what an abstract must contain, and the ICMJE says clinical trial abstracts should include the items CONSORT identified as essential. Keep the relevant list open while you draft and tick each item.

• Randomised trials. CONSORT 2025 item 1b asks for a structured summary of trial design, methods, results and conclusions. Its explanation paper updates the CONSORT for Abstracts item list, which includes the trial design and framework, how participants were allocated, who was blinded, numbers randomised and analysed in each group, the primary outcome result with effect size and precision, important harms, and the trial register name and number. The CONSORT item 1b page sets out the reasoning.
• Systematic reviews and meta-analyses. PRISMA 2020 for Abstracts is a 12-item checklist. It includes the information sources with the date each was last searched, the risk of bias method, a summary estimate with its confidence or credible interval if you ran a meta-analysis, the limitations of the evidence, and registration.
• Observational studies. STROBE item 1b asks for "an informative and balanced summary of what was done and what was found."
• Diagnostic accuracy studies. STARD for Abstracts lists the essential items for this design.

The ICMJE also recommends that the trial registration number appear at the end of the abstract. If your data are in a public repository, or you are reporting a secondary analysis, it asks you to give the data set identifier and repository name at the end of the abstract as well.

When the word limit bites, cut wording, not checklist items.

How to report results in a small space

The ICMJE asks for main findings with specific effect sizes and their statistical and clinical significance where possible, and warns against relying solely on P values, which fail to convey effect size and precision.

Five rules cover most of it:

1. Lead with the primary outcome. If the abstract focuses on a secondary outcome, name it as secondary and give the primary result too.
2. Give numbers for each group. Report absolute numbers alongside percentages, so readers can see the denominators.
3. Give the effect estimate with its confidence interval. That single figure shows size and precision together.
4. Report important harms. CONSORT 2025 warns that omitting them can seriously mislead. If there were none, say so.
5. Do not cherry-pick. CONSORT 2025 asks authors not to report only the statistically significant secondary outcomes or subgroup analyses.

Compare two versions of the same sentence:

The weak version tells the reader only that a threshold was crossed. The stronger one gives the denominators, the size of the difference and how precise it is. Use the same units and decimal places as your Results tables so each number can be checked line by line.

Write a conclusion the data support

The ICMJE asks abstracts to note important limitations and not to overinterpret findings. CONSORT 2025 defines spin as a distorted representation of study results and notes that abstracts frequently contain it. Overclaiming is also one of the habits covered in our post on what peer reviewers wish authors knew.

Use these decision rules:

• Every claim needs a result. Each statement in the conclusion should point to something already given under Results.
• Match the verb to the design. In an observational study, an exposure "was associated with" an outcome; it did not "reduce" or "cause" it.
• Name the population and setting. Do not generalise beyond the people you studied.
• Say so when the primary outcome showed no clear difference. Do not lead with a secondary finding instead.
• Be specific about next steps. If more studies are needed before the results are applied, say what kind.

Word limits, abbreviations and references

Word limits are set by each journal and can differ by article type. Check whether headings, the registration number and the funding statement count, and paste your text into the submission system's abstract field early in case it counts differently from your word processor. A short limit is a reason to write tightly, not to drop items: the developers of CONSORT for Abstracts found 250 to 300 words enough to cover every item on their trial checklist.

Ways to cut without losing content:

• Delete background sentences that could introduce any paper on the topic.
• Replace "In this study, we aimed to investigate whether" with "To determine whether".
• Compress secondary outcomes into one sentence, unless one is an important harm.
• Remove "novel" and "important", and "significant" wherever it has no statistical meaning.

Abbreviations should be few and standard. The ICMJE advises spelling out an abbreviation at first mention unless it is a standard unit of measurement, and keeping abbreviations out of the title. Because the abstract is often read alone, define each abbreviation at its first use in the abstract and again in the main text, and only abbreviate terms you repeat.

References should stay out unless the journal's instructions allow them. Readers often meet the abstract apart from the full text, so a citation number points nowhere, and the same goes for "see Table 1". Describe the gap in words instead.

Funding sources should be listed separately after the abstract, the ICMJE says, so that MEDLINE can display and index them properly. Follow your journal's template for exactly where.

A step-by-step drafting method

Write the final abstract last, from the finished manuscript. A rough early version can help co-authors agree on the main message, but rebuild it once the analyses and discussion are settled.

1. Read the journal's abstract rules. Headings, word limit for your article type, and what counts toward it.
2. Pick the abstract checklist for your design. CONSORT, PRISMA 2020 for Abstracts, or your guideline's abstract item.
3. Extract the facts from the manuscript. Copy them from the final text and tables, never from an earlier draft or from memory.
4. Draft the Results first. They decide what the Methods must explain and what the conclusion may claim.
5. Write Methods and Background around the results. Only the design details a reader needs to judge them.
6. Write a conclusion the results support. Apply the decision rules above.
7. Cut to the limit and check against the text. Trim wording, define abbreviations, and match every number to the manuscript.

A fill-in template

Adapt the labels to your journal's format before you use this.

Background: [One sentence on the clinical or scientific problem.] [One sentence on the specific gap this study addresses.]

Objective: To determine whether [intervention or exposure] [changes / is associated with] [primary outcome] in [population].

Methods: [Design] in [setting and study period]. [Number and description of participants, with key eligibility criteria.] [Intervention and comparator, or exposure groups.] The primary outcome was [outcome at time point]. [Main analysis.]

Results: Of [n] participants [randomised / included], [n] were analysed. [Primary outcome for each group, with absolute numbers and percentages]; [effect estimate, 95% CI]. [Most important secondary result or harm, or a statement that no important harms occurred.]

Conclusions: In [population and setting], [intervention or exposure] [finding, stated at the strength the design allows]. [Key limitation or implication, if space allows.]

Trial registration: [Registry name], [registration number].

For a systematic review, replace the Methods and Results content with the PRISMA 2020 for Abstracts items.

Mistakes that get abstracts flagged

Final checks before you submit

1. Headings and word count follow the journal's rules for this article type
2. Study design named, including in the title where the guideline asks for it
3. Primary outcome first, with numbers for each group and a confidence interval
4. Important harms reported, or their absence stated
5. Every number matches the main text, and the conclusion matches the Results
6. Abbreviations defined; no references or table citations
7. Registration number, and data set identifier if relevant, at the end

Once the abstract passes, work through the rest of our manuscript submission checklist. The Directive Publications author resources page links to its author guidelines and article type requirements, so read those before you draft. When the abstract and manuscript agree line for line, you can submit your manuscript.